# Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas

> **NCT06225999** · PHASE2 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 41 (actual)

## Conditions studied

- Metastatic Adenocarcinoma of the Pancreas

## Interventions

- **DRUG:** Irinotecan liposome injection (S095013)
- **DRUG:** Oxaliplatin
- **DRUG:** LLV (levoisomer form of leucovorin)
- **DRUG:** 5- FU (5-Fluorouracil)

## Key facts

- **NCT ID:** NCT06225999
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-25
- **Primary completion:** 2025-04-28
- **Final completion:** 2025-09-29
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225999, "Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06225999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*